Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 May;37:1220–1229.

L'incontinence urinaire en 1990 II: les traitements

L'urodynamie, pierre angulaire de la stratégie thérapeutique

Erik Schick, Jocelyne Tessier
PMCID: PMC2145377  PMID: 21229029

Abstract

Urodynamics has profoundly changed our understanding of the physiopathology of urinary incontinence which is, first and foremost, a functional problem. The urodynamic study is the only diagnostic tool which makes it possible to explore the functioning of the urethra and bladder. As such, it constitutes the cornerstone of our therapeutic strategy.

Full text

PDF
1220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bramble F. J. The treatment of adult enuresis and urge incontinence by enterocystoplasty. Br J Urol. 1982 Dec;54(6):693–696. doi: 10.1111/j.1464-410x.1982.tb13626.x. [DOI] [PubMed] [Google Scholar]
  2. Burgio K. L., Whitehead W. E., Engel B. T. Urinary incontinence in the elderly. Bladder-sphincter biofeedback and toileting skills training. Ann Intern Med. 1985 Oct;103(4):507–515. doi: 10.7326/0003-4819-103-4-507. [DOI] [PubMed] [Google Scholar]
  3. Furlow W. L. Postprostatectomy urinary incontinence: etiology, prevention, and selection of surgical treatment. Urol Clin North Am. 1978 Jun;5(2):347–352. [PubMed] [Google Scholar]
  4. Hilton P., Hertogs K., Stanton S. L. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):854–855. doi: 10.1136/jnnp.46.9.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hilton P., Stanton S. L. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol. 1982 Jun;54(3):252–255. doi: 10.1111/j.1464-410x.1982.tb06969.x. [DOI] [PubMed] [Google Scholar]
  6. Kinn A. C., Larsson P. O. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol. 1990;24(2):109–112. doi: 10.3109/00365599009180373. [DOI] [PubMed] [Google Scholar]
  7. Månsson W., Sundin T., Gullberg B. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. A double-blind study. Scand J Urol Nephrol. 1980;14(2):139–141. doi: 10.3109/00365598009179551. [DOI] [PubMed] [Google Scholar]
  8. Rittig S., Knudsen U. B., Nørgaard J. P., Pedersen E. B., Djurhuus J. C. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989 Apr;256(4 Pt 2):F664–F671. doi: 10.1152/ajprenal.1989.256.4.F664. [DOI] [PubMed] [Google Scholar]
  9. Schick E., Tessier J. L'incontinence urinaire en 1990. Can Fam Physician. 1991 Apr;37:879–885. [PMC free article] [PubMed] [Google Scholar]
  10. Scott F. B. The artificial sphincter in the management of incontinence in the male. Urol Clin North Am. 1978 Jun;5(2):375–391. [PubMed] [Google Scholar]
  11. Turner-Warwick R., Whiteside C. G., Milroy E. J., Pengelly A. W., Thompson D. T. The intravenous urodynamogram. Br J Urol. 1979 Feb;51(1):15–18. doi: 10.1111/j.1464-410x.1979.tb04237.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES